Is compounded semaglutide safe? Two questions are hiding in that one.
The first question is about the molecule: what are semaglutide's actual risks? The second is about the category: does "compounded" add risk? Both deserve straight answers, and neither answer is a simple yes or no, because safety in prescription medicine is not a property a product has; it is something a screening process produces, patient by patient. Here is each answer, plainly.
The molecule, honestly
Semaglutide's common effects are gastrointestinal: nausea, vomiting, diarrhea, constipation, and abdominal pain, most often while the dose is being adjusted. The serious risks in its labeling include pancreatitis, gallbladder disease, and kidney injury following the fluid loss that severe vomiting or diarrhea can cause, and FDA-approved semaglutide products carry a boxed warning concerning thyroid C-cell tumors observed in rodents. That warning is the reason a personal or family history of medullary thyroid carcinoma or MEN 2 is a contraindication here, and why the review asks about pancreatitis history, pregnancy plans, and any medication that lowers blood sugar. None of that biology cares which regulatory category your prescription came from, which is why our screening mirrors it either way. The full risk discussion lives on the product page and in your review; nothing on this page replaces either.
The category, honestly
Compounded semaglutide is not FDA-approved, and no compounded medication is, including this one. Compounded medicines are made to your individual prescription by a licensed pharmacy rather than manufactured and approved as a finished drug product. What determines whether a compounded prescription is trustworthy is the system around it: a real clinician review with the contraindications above taken seriously, a licensed US pharmacy accountable to state boards, semaglutide in its base form rather than the salt forms the FDA has warned about, and clear dosing instructions, because vial-and-syringe dosing errors are a documented hazard of this category and precise instructions are part of what a legitimate pharmacy provides. A seller missing any of those pieces has answered the safety question for you.
Questions
What happens if I am not approved?
You are not charged. Your clinician explains the reasoning and, where useful, what a better next step may be. Reviews are typically completed in under 24 hours.
Does the same answer apply to compounded tirzepatide?
The structure of the answer, yes: real class risks including pancreatitis and gallbladder disease, the same thyroid-history contraindication, and the same category logic. Tirzepatide's specifics live on its product page, and the same screening applies.
Who should not take this at all?
The hard exclusions include a personal or family history of medullary thyroid carcinoma or MEN 2, a history of pancreatitis, and pregnancy or planned pregnancy. The review exists to find the rest, case by case.
Ready when you are.
About 10 minutes. No charge unless your clinician approves.